JP Morgan Private Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$25.1M Sell
433,312
-140,345
-24% -$8.6M 0.07% 247
2023
Q2
$36.7M Sell
573,657
-301,125
-34% -$20.2M 0.19% 109
2023
Q1
$60.6M Sell
874,782
-41,710
-5% -$2.94M 0.13% 169
2022
Q4
$65.9M Buy
916,492
+40,855
+5% +$3.08M 0.15% 145
2022
Q3
$62.2M Buy
875,637
+59,663
+7% +$4.33M 0.16% 141
2022
Q2
$62.8M Buy
815,974
+150,973
+23% +$11.5M 0.16% 143
2022
Q1
$48.6M Buy
665,001
+20,451
+3% +$1.37M 0.11% 195
2021
Q4
$40.2M Sell
644,550
-33,127
-5% -$1.94M 0.09% 212
2021
Q3
$40.1M Sell
677,677
-503,640
-43% -$33.2M 0.1% 206
2021
Q2
$78.9M Sell
1,181,317
-13,783
-1% -$899K 0.2% 121
2021
Q1
$75.4M Sell
1,195,100
-47,711
-4% -$2.97M 0.24% 104
2020
Q4
$77.1M Sell
1,242,811
-17,130
-1% -$1.05M 0.25% 100
2020
Q3
$76M Buy
1,259,941
+70,847
+6% +$4.26M 0.3% 82
2020
Q2
$69.9M Buy
1,189,094
+100,219
+9% +$5.99M 0.32% 80
2020
Q1
$60.7M Sell
1,088,875
-14,717
-1% -$900K 0.34% 76
2019
Q4
$70.8M Buy
1,103,592
+275,176
+33% +$15.8M 0.32% 81
2019
Q3
$42M Buy
828,416
+153,758
+23% +$7.23M 0.22% 112
2019
Q2
$30.6M Sell
674,658
-79,200
-11% -$3.69M 0.17% 136
2019
Q1
$36M Buy
753,858
+177,440
+31% +$8.84M 0.19% 121
2018
Q4
$30M Buy
576,418
+248
+0% +$13.3K 0.18% 128
2018
Q3
$35.8M Sell
576,170
-28,567
-5% -$1.7M 0.17% 134
2018
Q2
$33.5M Buy
604,737
+47,545
+9% +$2.57M 0.19% 130
2018
Q1
$35.2M Buy
557,192
+81,856
+17% +$5.27M 0.24% 102
2017
Q4
$29.1M Buy
475,336
+24,612
+5% +$1.54M 0.19% 124
2017
Q3
$28.7M Buy
450,724
+133,778
+42% +$7.81M 0.21% 116
2017
Q2
$17.7M Buy
316,946
+31,325
+11% +$1.7M 0.13% 160
2017
Q1
$15.5M Buy
285,621
+49,388
+21% +$2.71M 0.12% 172
2016
Q4
$13.8M Sell
236,233
-14,142
-6% -$773K 0.12% 171
2016
Q3
$13.5M Buy
250,375
+10,365
+4% +$666K 0.13% 168
2016
Q2
$17.7M Buy
240,010
+689
+0.3% +$48.7K 0.17% 133
2016
Q1
$15.3M Buy
239,321
+51,447
+27% +$3.24M 0.15% 135
2015
Q4
$12.9M Buy
187,874
+13,467
+8% +$890K 0.13% 157
2015
Q3
$10.3M Sell
174,407
-20,138
-10% -$1.28M 0.13% 158
2015
Q2
$12.9M Buy
194,545
+21,265
+12% +$1.4M 0.15% 158
2015
Q1
$11.2M Buy
173,280
+5,397
+3% +$338K 0.13% 170
2014
Q4
$9.91M Buy
167,883
+7,701
+5% +$434K 0.12% 185
2014
Q3
$8.2M Buy
160,182
+22,461
+16% +$1.12M 0.11% 198
2014
Q2
$6.68M Buy
137,721
+17,944
+15% +$884K 0.11% 181
2014
Q1
$6.22M Buy
119,777
+7,907
+7% +$421K 0.11% 178
2013
Q4
$5.95M Buy
111,870
+23,533
+27% +$1.2M 0.12% 176
2013
Q3
$4.09M Sell
88,337
-5,211
-6% -$229K 0.09% 195
2013
Q2
$4.18M Buy
+93,548
New +$4.06M 0.1% 184

Other funds holding BMY

JP Morgan Private Wealth Advisors's BMY Position: Q3 2023 in Review

JP Morgan Private Wealth Advisors reduced its Bristol-Myers Squibb (BMY) stake by 24% in Q3 2023, selling an estimated $8.6M and leaving 433,312 shares worth $25.1M. The position accounts for 0.07% of the portfolio, ranked #247.

JP Morgan Private Wealth Advisors first reported a position in BMY in Q2 2013 and has held it in 42 quarters since. The position peaked at $78.9M in Q2 2021. 2,389 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

  • JP Morgan Private Wealth Advisors held 433,312 shares of Bristol-Myers Squibb worth $25.1M as of Q3 2023.
  • JP Morgan Private Wealth Advisors sold 140,345 Bristol-Myers Squibb shares in Q3 2023, an estimated $8.6M.
  • Bristol-Myers Squibb made up 0.07% of JP Morgan Private Wealth Advisors's portfolio in Q3 2023, its #247 holding.
  • JP Morgan Private Wealth Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 42 quarters since.
  • JP Morgan Private Wealth Advisors's Bristol-Myers Squibb position peaked at $78.9M in Q2 2021.
  • 2,389 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.